$15.730
-0.967 (-6.15%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de AKTS por análisis de gráficos similares
Alphio's AKTS stock price prediction model matches the current Aktis Oncology Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $15.83 (+0.65%). The 1-week path is $15.92 (+1.23%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Aktis Oncology Inc?
Aktis Oncology (AKTS) appears to be a good buy right now, especially given its current price of $15.73, which is significantly below the analyst price targets of $40 and $35. The company has a strong gross margin of 100%, indicating effective cost management in its operations. However, it is important to note the risk of its net income, which has been negative, with a reported net income of -24,144,000 USD in Q2 2026. This financial performance, combined with the potential upside indicated by the analyst ratings, supports a buy recommendation.
AKTS cerró en $15.73 el Friday, tras bajar -6.15%
Aktis Oncology Inc (AKTS) last closed at $15.73, losing -6.15%. These facts feed the 1-day and 1-week AKTS price prediction above.
Consenso de analistas
Aktis Oncology Inc (AKTS): 3 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Aktis Oncology Inc (AKTS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de AKTS, ordenadas por similitud.
Análisis de estacionalidad de AKTS
Historically the probability of a positive October return for AKTS is 0.00%. August offers the highest probability of a positive month at 46.51%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.